Biotricity Inc (BTCY) USD0.001

Sell:$0.51Buy:$0.51No change

Prices delayed by at least 15 minutes
Sell:$0.51
Buy:$0.51
Change:No change
Prices delayed by at least 15 minutes
Sell:$0.51
Buy:$0.51
Change:No change
Prices delayed by at least 15 minutes

Company Information

About this company

Biotricity Inc. is a medical technology company focused on biometric data monitoring and diagnostic solutions. The Company developed its Bioflux technology, comprised of a monitoring device and software components. The Bioflux device is comprised of a wet electrode worn on a belt clip around the waist. The Bioflux ECG reporting software enables doctors and labs to view a patient’s electrocardiogram (ECG) data for monitoring and diagnostic purposes. Its Bioflux platform has a built-in cellular chipset and a real-time embedded operating system, which allows for its technology to be utilized as an Internet of Things (IoT) platform. It has developed several technologies, including Biotres, Bioheart, and Biocare. Biotres is an ECG Holter solution that addresses the limitations of existing solutions in the Holter market. Bioheart is a personal cardiac monitoring solution for consumers. Biocare is a cardiac disease management platform for chronic care management and remote patient monitoring.

Key people

Waqaas Al-Siddiq
Chairman of the Board, President, Chief Executive Officer
John Ayanoglou
Chief Financial Officer
Ronald Mcclurg
Independent Director
David A. Rosa
Independent Director
Chester White
Independent Director
Click to see more

Key facts

  • EPIC
    BTCY
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Medical Equipment & Supplies
  • ISIN
    US09074H2031
  • Market cap
    $12.87m
  • Employees
    55
  • Shares in issue
    24.75m
  • Exchange
    Over The Counter
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.